Kwsh CTI Announces Results from Preclinical Study of PIXUVRI Presented at the AACR-NCI-EORTC Meeting
LAHORE
akistan鈥檚 trade deficit reached a record level of $30 billion in 2016-17, demonstrating a jump of 42% compared to the last financial year. Exports have declined by 3% to $18.5 billion while imports have gone up by 21% to $48.5 billion.鈥淭his decline is disconcerting, since our country has never faced imports being two-and-a-half times as much as current exports,鈥?said All Pakistan Busi
adidas campus verte ness Forum (APBF) President Ibrahim Qureshi, expressing concern over the worrying numbers.With govt fixated on Panamagate, state business
newbalance 550 suffers鈥淧akistan faces this unprecedented trade deficit despite the prevalence of low international prices of our biggest import; oil.鈥滱 number of reasons can be attributed to the drastic drop in exports, which includes structural factors and erroneous policies.Unlike the Middle East o
newbalance 550 r East Asia, Pakistan has followed a traditional policy of import substitution rather than export promotion. Therefore, little emphasis has been given on broadening exports that hav A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.The test, known as a 鈥榣iquid biopsy鈥? detects cancer DNA in the bloodstream to reveal if stomach and oesophageal cancers are being driven by the presence
yeezy slide of too many copies of a gene known as EGFR.Researchers think the test, which is less painful than mor
nike air forces 1 e invasive tissue biopsies, could be used to identify patients who might benefit from drugs that block EGFR activity, such as panitumumab.The research team, at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, also showed that EGFR inhibitor
nike dunks panda s should never be combined with the chemotherapy drug epirubicin as their effects seem to cancel each other out.The findings explain why previous trials combining these drugs failed and have major implications for the design of future trials in gastro-oesophageal and other cancers, such as breast cancer